BUPROPION, better known as Zyban, may help with smoking cessation, says a pharmaceutical industry-funded study from the Center for Tobacco Research and Intervention at the University of Wisconsin-Madison. Research on 893 subjects found the anti-depressant tripled quit rates among women and smokers with a history of depression, as compared to those taking placebos.


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.